CD4 and type 1 diabetes mellitus: In this view, decreased effector CD4+ T cell functions and increased regulatory CD4+ T cell functions were observed following treatment of NOD mice (model for type I diabetes) with the B-cell maturation antigen (BCMA)-Fc construct, which blocks BLyS-mediated survival signals for B cells.